肿瘤抗原负载的DC-CIK细胞增殖能力及对肝癌细胞HepG2的杀伤活性研究  

Study of proliferation ability of tumor antigen-loaded DC-CIK cells and its killing effect on hepatocarcinoma cells HepG2

作　　者：王福立[1] 孙银萍[1] 魏本尊[2] 秦杰[3] 刘振国[3] 李岩[4] 邱菊[5] Wang Fuli;Sun Yinping;Wei Benzun;Qin Jie;Liu Zhenguo;Li Yan;Qiu Ju(Department of Oncology,Zibo Central Hospital,Shandong Province,Zibo 255000,China;Department of Hepatobiliary Surgery,Zibo Central Hospital,Shandong Province,Zibo 255000,China;Department of Oncology,Gaoqing People's Hospital,Shandong Province,Gaoqing 256300,China;Department of Oncology,Qianfoshan Hospital of Shandong University,Shandong Province,Jinan 250014,China;Department of Ultrasound,Zibo Central Hospital,Shandong Province,Zibo 255000,China)

机构地区：[1]山东省淄博市中心医院肿瘤科,255000 [2]山东省淄博市中心医院肝胆外科,255000 [3]山东省高青县人民医院肿瘤科,256300 [4]山东大学附属千佛山医院肿瘤科,济南250014 [5]山东省淄博市中心医院超声科,255000

出　　处：《国际肿瘤学杂志》2019年第1期1-5,共5页Journal of International Oncology

摘　　要：目的观察肿瘤抗原负载的树突状细胞(DC)与细胞因子诱导的杀伤细胞(CIK)共培养后的增殖能力及对肝癌细胞HepG2的杀伤活性。方法采用液氮反复冻融法制备肝癌细胞HepG2抗原。应用血细胞分离机采集健康供血者单个核细胞,诱导并分离出DC、CIK,用肿瘤抗原冲击DC获得Ag-DC,将CIK分为3组,一组为单纯CIK,二组以DC∶CIK=1∶5比例混合,三组以Ag-DC∶CIK=1∶5比例混合。3组细胞分别记作:CIK组、DC-CIK组和Ag-DC-CIK组。观察3组细胞的增殖能力和细胞表型,并用四甲基偶氮唑蓝(MTT)法测定3组细胞对肝癌细胞HepG2的杀伤活性。结果3组细胞随着培养时间的延长增殖速度逐渐增快,在共同培养的第9天、第12天和第15天时Ag-DC-CIK的增殖倍数(61.32±1.72、190.83±3.53、399.09±5.60)均明显高于同时间CIK的增殖倍数(22.47±2.07、55.91±1.81、83.20±2.34)和DC-CIK的增殖倍数(40.26±2.49、125.03±4.16、251.55±3.25),3组间差异有统计学意义(F=185.78,P=0.033;F=297.35,P=0.018;F=455.37,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.05)。Ag-DC-CIK对HepG2细胞的杀伤活性在效靶比为5∶1、10∶1和20∶1时分别为31.71%±0.29%、42.43%±1.86%和57.69%±1.11%,均显著高于CIK组(12.11%±1.14%、21.30%±0.52%和30.71%±1.26%)和DC-CIK组(20.06%±0.67%、29.89%±1.37%和39.11%±0.92%),3组间差异有统计学意义(F=159.64,P=0.037;F=199.36,P=0.025;F=302.08,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.05)。CIK、DC-CIK和Ag-DC-CIK 3组细胞培养至第15天,流式细胞仪分析表明3组细胞均表达CD3^+CD8^+、CD3^+CD56^+双阳性细胞,且Ag-DC-CIK组CD3^+CD8^+、CD3^+CD56^+双阳性细胞的含量(88.12%±1.24%、61.35%±2.63%)明显高于CIK组(54.37%±3.08%、18.22%±1.83%)和DC-CIK组(69.80%±1.46%、39.51%±2.17%),3组间差异有统计学意义(F=414.32,P<0.001;F=378.60,P<0.001),进一步两两比较发现,差异均具有统计学意义(均P<0.001)。结论肿瘤抗ObjectiveTo observe the proliferation ability of cocultured dendritic cells(DCs)loaded with tumor antigen and cytokine-induced killer cells(CIKs)and its killing effect on hepatocarcinoma cells HepG2.MethodsThe antigen of hepatocarcinoma cells HepG2 was prepared by repeated freezing and thawing of liquid nitrogen.Peripheral blood mononuclear cells(PBMNCs)were isolated from healthy donors by blood cell separator,then DCs and CIKs were induced.Ag-DCs were obtained by impinging DCs with tumor antigens.CIKs were divided into three groups:the first group was CIKs alone,the second group was mixed in the proportion of DCs∶CIKs=1∶5,and the third group was mixed in the proportion of Ag-DCs∶CIKs=1∶5.The three groups of cells were recorded as CIK group,DC-CIK group and Ag-DC-CIK group.The proliferation and cell phenotype of the three groups of cells were observed and the killing effects on hepatocarcinoma cells HepG2 were detected by methyl thiazolyl tetrazolium(MTT)assay.ResultsThe proliferation multiples of the three groups of cells were gradually increased with the prolongation of culture time,and the proliferation rates of Ag-DC-CIK on the 9th day(61.32±1.72),the 12th day(190.83±3.53)and the 15th day(399.09±5.60)were significantly higher than those of CIK group(22.47±2.07,55.91±1.81,83.20±2.34)and DC-CIK group(40.26±2.49,125.03±4.16,251.55±3.25),and the difference between the three group was statistically significant(F=185.78,P=0.033;F=297.35,P=0.018;F=455.37,P<0.001),in addition,the differences between each two groups were statistically significant(all P<0.05).The cytotoxicity of Ag-DC-CIK to HepG2 cells at the effective target ratios of 5∶1(31.71%±0.29%),10∶1(42.43%±1.86%)and 20∶1(57.69%±1.11%)were significantly higher than those of CIK group(12.11%±1.14%,21.30%±0.52%,30.71%±1.26%)and DC-CIK group(20.06%±0.67%,29.89%±1.37%,39.11%±0.92%),and the difference between the three group was statistically significant(F=159.64,P=0.037;F=199.36,P=0.025;F=302.08,P<0.001),in addition,the differences

关 键 词：树突细胞 杀伤细胞 细胞系 肿瘤 

分 类 号：R735.7[医药卫生—肿瘤]